Hypoxia PET Tracers in EBRT Dose Planning in Head and Neck Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|8|1|32-37

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.8, Iss.1, 2015-05, pp. : 32-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDG-PET worthwhile in head and neck cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Chemotherapy in head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Multidisciplinary Symposium on Head and Neck Cancer

By Agulnik Mark   Siu Lillian L  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 489-494

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for head and neck cancer

By Rhee John C   Khuri Fadlo R   Shin Dong M  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 91-104

Informa Healthcare

Access to resources Recommend Favorite

Improving management of head and neck cancer

By  

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite